Key Financial’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Other funds holding INO
Key Financial's INO Position: Q3 2026 in Review
Key Financial held its Inovio Pharmaceuticals (INO) position steady in Q3 2026 at 14 shares worth $17. The position accounts for ﹤0.01% of the portfolio, ranked #1303.
Key Financial first reported a position in INO in Q2 2021 and has held it in 17 quarters since. The position peaked at $1K in Q1 2022. 79 funds tracked by Wall St. Rank hold INO as of Q3 2026.
- Key Financial held 14 shares of Inovio Pharmaceuticals worth $17 as of Q3 2026.
- Key Financial left its Inovio Pharmaceuticals share count unchanged in Q3 2026.
- Inovio Pharmaceuticals made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #1303 holding.
- Key Financial first reported a position in Inovio Pharmaceuticals in Q2 2021 and has held it in 17 quarters since.
- Key Financial's Inovio Pharmaceuticals position peaked at $1K in Q1 2022.
- 79 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2026.
Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.